Skip to main content
ACAD logo

ACAD

Acadia Pharmaceuticals Inc
$25.92 +0.43 (+1.69%) At close · Jul 15
Market Cap
$4.39B
Shares
171,235,870

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 342
Total Value: $3,489,840,956
Total Shares: 156,726,075
Showing 1–100 of 354 holdings by value · page 1 of 4

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 343 13F filers
Top Holder
27.3%
Jun 2023 → Mar 2026 · range 24.5% – 27.3%
of institutional value
Top 5
54.5%
Jun 2023 → Mar 2026 · range 51.8% – 56.8%
of institutional value
Top 10
64.4%
Jun 2023 → Mar 2026 · range 62.2% – 68.0%
of institutional value
HHI
1,037
Jun 2023 → Mar 2026 · range 909 – 1,037
Broadly held
Showing 100 of 354
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1070494 CUSIP 004225108 13F (30d) 26 filings 25 filers Visit website Investor relations